Li, L., Liu, S., Wang, Q., Wang, Y., & Yu, G. (2024). Hepatic artery infusion chemotherapy with systemic capecitabine and camrelizumab for treating unresectable hilar cholangiocarcinoma: An initial investigation of efficacy and safety Journal of cancer research and therapeutics, 20(2), 578-583. https://doi.org/10.4103/jcrt.jcrt_1549_23
Chicago Style (17th ed.) CitationLi, Long, Song Liu, Qingdong Wang, Yanhua Wang, and Guangji Yu. "Hepatic Artery Infusion Chemotherapy with Systemic Capecitabine and Camrelizumab for Treating Unresectable Hilar Cholangiocarcinoma: An Initial Investigation of Efficacy and Safety." Journal of Cancer Research and Therapeutics 20, no. 2 (2024): 578-583. https://doi.org/10.4103/jcrt.jcrt_1549_23.
MLA (9th ed.) CitationLi, Long, et al. "Hepatic Artery Infusion Chemotherapy with Systemic Capecitabine and Camrelizumab for Treating Unresectable Hilar Cholangiocarcinoma: An Initial Investigation of Efficacy and Safety." Journal of Cancer Research and Therapeutics, vol. 20, no. 2, 2024, pp. 578-583, https://doi.org/10.4103/jcrt.jcrt_1549_23.